Araksya Izmiryan
0000-0002-6358-6980
3 papers found
Refreshing results…
Highly Efficient Ex Vivo Correction of COL7A1 through Ribonucleoprotein-Based CRISPR/Cas9 and Homology-Directed Repair to Treat Recessive Dystrophic Epidermolysis Bullosa
Human OTULIN haploinsufficiency impairs cell-intrinsic immunity to staphylococcal α-toxin
EBGene trial: patient preselection outcomes for the European GENEGRAFT ex vivo phase I/II gene therapy trial for recessive dystrophic epidermolysis bullosa
Missing publications? Search for publications with a matching author name.